Summary: GLP-1 receptor agonists are not licensed or recommended for treating IBS and may worsen symptoms due to gastrointestinal side effects
Importantly, despite the evidence for use of SGLT-2 inhibitors for DKD treatment, they should not be used in patients with type 1 diabetes because of the risk of euglycaemic diabetic ketoacidosis
In general, weight loss medications are recommended for people who: Have a body mass index (BMI) of 30 or higher Have a BMI of 27 or higher, plus a weight-related condition like high blood pressure or type 2 diabetes Find out how much you could lose Provide your biometric data to get started
avoid storing medications in this range Signs Your Medication Has Been Compromised Inspect your medication before each injection: Visual Changes : Properly stored GLP-1 medication should be clear and colorless (cloudy insulin formulations excepted)
And more importantly, will it ever go away? If youre taking a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Zepbound, youre not alone in experiencing nausea
